Since our founding in 2001, Vystar Corporation has been dedicated to one cause: creating a natural rubber latex (NRL) with all the properties of NRL but without the allergy-causing proteins. The early years: From 2001-2007, operations focused on the early stage research, development, testing and commercialization of the product that is now patented and trademarked as Vytex® NRL, a revolutionary all-natural raw material that significantly reduces antigenic proteins found in natural rubber latex. In 2007, we were named a “Top Ten Innovative Technology Company” by the Technology Association of Georgia (TAG). Last year: In 2008, we finalized our toll manufacturing agreement with Revertex Malaysia, and Universal Capital Management, Inc. named Vystar Corp. as one of its portfolio companies. The present: Early in 2009, we signed an agreement with Centrotrade Minerals and Metals, Inc. and Centrotrade Deutschland, GmbH, to distribute Vytex® Natural Rubber Latex (NRL), to manufacturers in North America and Europe.

Later in the year, the market welcomed the first product made with the revolutionary Vytex NRL, the Envy™ Ultra Thin condom, manufactured by Alatech Healthcare LLC of Eufaula, Alabama. This product gives the consumer first-hand experience with the remarkable benefits of Vytex NRL. In addition to the condom market, Vystar is working with manufacturers across a broad range of consumer and medical products to bring Vytex NRL to market in adhesives, foams, surgical and exam gloves, other medical devices and, natural rubber latex foam mattresses, pillows and sponges.